FRANKFURT (Reuters) - The market for cheap copies of biotech drugs could initially be dominated by the very companies that develop these drugs, rather than established generic drug makers, the outgoing head of Switzerland's Actavis said. The m...
Source: http://health.yahoo.net/news/s/nm/actavis-ceo-originators-to-have-edge-in-biosimilars
Scarlett Johansson Medal of Honor Lion King The Vampire Diaries
No comments:
Post a Comment
Note: only a member of this blog may post a comment.